Erythropoietin Effects After Traumatic Brain Injury
NCT00260052 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL
Last updated 2015-08-24
Summary
To determine if the early administration of erythropoietin to patients sustaining traumatic brain injury will reduce secondary brain injury.
Conditions
Interventions
- DRUG
-
Erythropoietin administration
Sponsors & Collaborators
-
Medical College of Wisconsin
lead OTHER
Principal Investigators
-
Ram Nirula, MD, MPH · Medical College of Wisconsin
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-31
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
NCT03110341 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1
NCT01239706 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy
NCT01732146 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Erythropoietin on Preterm Brain Injury
NCT02036073 ·Status: COMPLETED ·Phase: PHASE4
-
TETRAM 2. Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study
NCT00478517 ·Status: WITHDRAWN ·Phase: PHASE1
-
Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants
NCT02076373 ·Status: UNKNOWN ·Phase: PHASE3
-
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
NCT00910234 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)
NCT00945789 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
NCT03914690 ·Status: COMPLETED ·Phase: PHASE2
-
Erythropoietin in HIE Neonate
NCT06590155 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
NCT00513240 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial
NCT02564796 ·Status: TERMINATED ·Phase: PHASE2
-
Does Erythropoietin Improve Outcome in Very Preterm Infants?
NCT00413946 ·Status: COMPLETED ·Phase: PHASE2
-
Neuroprotective Role of Erythropoietin in Perinatal Asphyxia
NCT02002039 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage
NCT03390530 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety and Efficacy of Multiple EPO Injections in Children With Cerebral Palsy
NCT03303573 ·Status: COMPLETED
-
ESWT as a Treatment for Chronic NHO in TBI Patients
NCT02331628 ·Status: COMPLETED ·Phase: NA
-
Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?
NCT00265486 ·Status: UNKNOWN
-
High-dose Erythropoietin for Asphyxia and Encephalopathy
NCT02811263 ·Status: COMPLETED ·Phase: PHASE3
-
Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy
NCT00808704 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Erythropoietin and Pediatric Cardiac Surgery
NCT00451698 ·Status: TERMINATED ·Phase: NA
-
Erythropoietin in Premature Infants to Prevent Encephalopathy
NCT02550054 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients
NCT03882060 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants
NCT01235923 ·Status: COMPLETED ·Phase: PHASE2
-
Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
NCT03163589 ·Status: UNKNOWN ·Phase: PHASE3